Publication, Part of National Diabetes Audit: Non-Diabetic Hyperglycaemia, Diabetes Prevention Programme
Non-Diabetic Hyperglycaemia, 2020-21, Diabetes Prevention Programme
Care processes: Glycaemic tests and BMI
NICE recommendation
‘People at high risk of developing type 2 diabetes should be offered a blood test and assessment of their BMI at least once a year.’
Table 2: Patient monitoring within the audit period1,2, GP-recorded non-diabetic hyperglycaemia (NDH), 2019-20 / 2020-21, England
| 2019-20 | 2020-21 | |||
| Care process | Number | Per cent | Number | Per cent |
| Any glycaemic test | 1,670,925 | 78.1 | 1,597,930 | 67.2 |
| - Fasting plasma glucose | 101,425 | 4.7 | 65,305 | 2.7 |
| - HbA1c | 1,655,190 | 77.3 | 1,588,550 | 66.8 |
| Body Mass Index (BMI) | 1,367,825 | 63.9 | 1,091,480 | 45.9 |
| BMI and glycaemic test | 1,199,455 | 56.0 | 925,280 | 38.9 |
1. People included: those registered at a GP practice that participated in NDA 2019-20 / 2020-21.
2. 2,140,090 people were recorded with non-diabetic hyperglycaemia in NDA 2019-20.
2,378,485 people were recorded with non-diabetic hyperglycaemia in NDA 2020-21.
- In 2020-21, fewer people with NDH were monitored for BMI and glycaemic testing.
- However, despite the pressures of the COVID-19 pandemic, more than two-thirds of people with non-diabetic hyperglycaemia had a HbA1c or fasting plasma glucose test.
Figure 4: Patient monitoring within the audit period1,2, by CCG, GP-recorded non-diabetic hyperglycaemia (NDH), 2019-20 - 2020-21, England
1. People included: those registered at a GP practice that participated in NDA 2019-20 / 2020-21.
2. 2,140,090 people were recorded with non-diabetic hyperglycaemia in NDA 2019-20.
2,378,485 people were recorded with non-diabetic hyperglycaemia in NDA 2020-21.
- In 2019-20, the median level of glycaemic tests undertaken in CCGs was at 79%; in 2020-21 this was 66%.
- In 2019-20, the median level of BMI measurements undertaken in CCGs was at 64%; in 2020-21 this was 45%.
1. People included: those registered at a GP practice that participated in 2020-21.
2. 2,378,485 people were recorded with non-diabetic hyperglycaemia in NDA 2020-21.
Table 3: Patient monitoring within the audit period1,2, GP-recorded non-diabetic hyperglycaemia (NDH), by demographic breakdown, by diagnosis year, 2020-21, England.
| Care process | Glycaemic test (%) | Body Mass Index (%) | ||
| Diagnosis year | 2020-21 | Other | 2020-21 | Other |
| All | 92.4 | 61.9 | 59.1 | 43.1 |
| Sex – Male | 92.1 | 60.1 | 59.9 | 42.2 |
| Sex – Female | 92.5 | 62.7 | 58.6 | 43.5 |
| Ethnicity – White | 93.1 | 62.7 | 61.0 | 44.9 |
| Ethnicity – Asian | 91.2 | 61.3 | 57.5 | 39.8 |
| Ethnicity – Black | 89.4 | 56.2 | 59.6 | 41.0 |
| Ethnicity – Mixed | 90.3 | 57.0 | 58.6 | 40.5 |
| Ethnicity – Other | 90.3 | 59.7 | 62.0 | 43.2 |
| Age – Under 40 | 89.8 | 46.0 | 58.4 | 36.6 |
| Age – 40 to 64 | 91.8 | 56.2 | 59.1 | 39.0 |
| Age – 65 to 79 | 93.6 | 66.9 | 59.8 | 45.5 |
| Age – 80 + | 92.8 | 67.1 | 59.0 | 48.6 |
| Deprivation – IMD 1 | 93.5 | 60.7 | 62.6 | 45.4 |
| Deprivation – IMD 2 | 91.3 | 60.9 | 59.8 | 44.3 |
| Deprivation – IMD 3 | 91.8 | 62.0 | 58.3 | 42.8 |
| Deprivation – IMD 4 | 92.6 | 62.1 | 57.9 | 41.5 |
| Deprivation – IMD 5 | 92.4 | 61.9 | 57.2 | 40.0 |
1. People included: those registered at a GP practice that participated in 2020-21.
2. 2,378,485 people were recorded with non-diabetic hyperglycaemia in NDA 2020-21.
- 8 per cent of people diagnosed with NDH in 2020-21 did NOT have a glycaemic test done in the audit period.
- People diagnosed with NDH in 2020-21 were more likely to have a BMI care process completed in the audit period – 59% – than people diagnosed earlier – 43%.
- Overall, in 2020-21, people with NDH were more likely to have had their care processes if they were aged 65 and over.
- There was relatively little difference in care processes across areas of different deprivation.
Last edited: 21 July 2023 1:06 pm